blog | Minimed

Skip to content

Login

Login

Subscribe to our Newsletter

Go Back to Home

Go Back to Blog

IPOs, Nasdaq, Medline, 2026, Minimed

MiniMed Group Launches IPO as Scaled $2.3 Billion Revenue Diabetes Technology Business Seeks Nasdaq Listing at Approximately $7–8 Billion Implied Market Capitalization

$Picture of {{ content.blog_author.display_name }}$ Eric Friedman

Feb 24, 2026 1:04:33 PM

Subscribe to our Newsletter

Email

NONE OF THE CONTENT PUBLISHED ON THE WEBSITE OR MOBILE APP CONSTITUTES A RECOMMENDATION, SOLICITATION, ENDORSEMENT, OR OFFER BY IPO PROPHET™ OR ITS AFFILIATES TO BUY OR SELL ANY SECURITIES, FUTURES, OPTIONS, OR OTHER FINANCIAL INSTRUMENTS, OR PROVIDE ANY INVESTMENT ADVICE OR SERVICE.